发布求助
文献互助 智能选刊 最新文献

Im Focus Onkologie最新文献

筛选
英文 中文
Erhaltungstherapie beim Ovarialkarzinomrezidiv
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4319-x
K. Arnheim
{"title":"Erhaltungstherapie beim Ovarialkarzinomrezidiv","authors":"K. Arnheim","doi":"10.1007/s15015-018-4319-x","DOIUrl":"https://doi.org/10.1007/s15015-018-4319-x","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"28 1","pages":"76 - 76"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73702907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Onkologische Rehabilitation — Basis für die Qualität des Langzeitüberlebens 放射改造中心
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4302-6
O. Rick
{"title":"Onkologische Rehabilitation — Basis für die Qualität des Langzeitüberlebens","authors":"O. Rick","doi":"10.1007/s15015-018-4302-6","DOIUrl":"https://doi.org/10.1007/s15015-018-4302-6","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"20 1","pages":"65-68"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83168600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
MCL-Patienten in Studien am besten aufgehoben 治疗mcl患者最有效的方法
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4295-1
Peter Leiner
{"title":"MCL-Patienten in Studien am besten aufgehoben","authors":"Peter Leiner","doi":"10.1007/s15015-018-4295-1","DOIUrl":"https://doi.org/10.1007/s15015-018-4295-1","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"199 1","pages":"51"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77721639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kolorektales Karzinom: Bluttest auf RAS-Mutationen scheint zuverlässig 离异突变的血液检测似乎非常可靠
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4276-4
J. Neumaier
{"title":"Kolorektales Karzinom: Bluttest auf RAS-Mutationen scheint zuverlässig","authors":"J. Neumaier","doi":"10.1007/s15015-018-4276-4","DOIUrl":"https://doi.org/10.1007/s15015-018-4276-4","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"3 1","pages":"36"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81656574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuer Standard: Checkpointhemmung beim NSCLC bringt Überlebensvorteil 新标准，nct lc的通话取消了
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4267-5
Peter Leiner
{"title":"Neuer Standard: Checkpointhemmung beim NSCLC bringt Überlebensvorteil","authors":"Peter Leiner","doi":"10.1007/s15015-018-4267-5","DOIUrl":"https://doi.org/10.1007/s15015-018-4267-5","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"30 1","pages":"25"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74138982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
„Nothing about us without us“ — auch in der Forschung? “没有我们就没有我们”——在《未来》里?
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4260-z
Springer Medizin
{"title":"„Nothing about us without us“ — auch in der Forschung?","authors":"Springer Medizin","doi":"10.1007/s15015-018-4260-z","DOIUrl":"https://doi.org/10.1007/s15015-018-4260-z","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"87 1","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73558131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AR-Blocker wirkt Metastasierung von CRPC entgegen 在crl中
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4279-1
Kathrin von Kieseritzky
{"title":"AR-Blocker wirkt Metastasierung von CRPC entgegen","authors":"Kathrin von Kieseritzky","doi":"10.1007/s15015-018-4279-1","DOIUrl":"https://doi.org/10.1007/s15015-018-4279-1","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"12 1","pages":"39"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86805322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patienten mit mNSCLC profitieren unabhängig von der PD-L1-Expression von einer PD-1-Blockade 直到12岁
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4262-x
J. Neumaier, B. Hackanson
{"title":"Patienten mit mNSCLC profitieren unabhängig von der PD-L1-Expression von einer PD-1-Blockade","authors":"J. Neumaier, B. Hackanson","doi":"10.1007/s15015-018-4262-x","DOIUrl":"https://doi.org/10.1007/s15015-018-4262-x","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"41 1","pages":"13-14"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85460125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liquid Biopsy korreliert mit Gewebeanalyse 流体生物和组织分析相关
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4318-y
N. Siegmund-Schultze
{"title":"Liquid Biopsy korreliert mit Gewebeanalyse","authors":"N. Siegmund-Schultze","doi":"10.1007/s15015-018-4318-y","DOIUrl":"https://doi.org/10.1007/s15015-018-4318-y","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"68 1","pages":"76 - 76"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90903878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Checkpointinhibition bei Kopf-Hals-Tumoren
Im Focus Onkologie Pub Date : 2018-11-01 DOI: 10.1007/s15015-018-4322-2
Red.
{"title":"Checkpointinhibition bei Kopf-Hals-Tumoren","authors":"Red.","doi":"10.1007/s15015-018-4322-2","DOIUrl":"https://doi.org/10.1007/s15015-018-4322-2","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":"5 1","pages":"77 - 77"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78476918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信